Pharma Supply Chain & Logistics Innovation Programme

The State of Pharmaceutical Supply Chains in 2027: Risks, Pressures and Priorities

• Dependence on overseas APIs, raw materials and critical suppliers
• Building resilience without dramatically increasing cost

Beyond Cost Savings: How Strategic Procurement Can Drive Margin, Resilience and Innovation

Cold Chain 2.0: Protecting Temperature-Sensitive Medicines

• Real-time monitoring, IoT and connected packaging
• Managing temperature excursions and product integrity
• Reducing cold-chain costs while improving reliability

AI-Powered Supply Chains: From Forecasting to Predictive Decision-Making

• AI for demand forecasting and inventory optimization
• Predicting supplier, manufacturing and logistics risks
• Moving from reactive management to predictive operations

DSCSA, Serialization and End-to-End Traceability: What Comes Next?

• Enhancing DSCSA compliance through seamless serialization, data sharing, and trading-partner interoperability
• Leveraging end-to-end traceability to improve product security, recall readiness, and supply chain visibility

Inventory Optimization: Balancing Service Levels, Working Capital and Supply Security

• Optimizing inventory levels to maintain service levels while reducing excess stock and working capital
• Strengthening supply security through safety-stock strategies, demand forecasting, and scenario planning

Resilient Pharma Supply Chain

From Supplier to Patient: Building True End-to-End Visibility

• Connecting suppliers, manufacturers, logistics and distributors
• Control towers, track-and-trace and real-time data

Quality Risk Management for External Manufacturing of Sterile Injectables

• Integrating QRM, deviations, CAPA, change control, batch disposition and supply risk

The 2030 Pharma Supply Chain: What Must Change Now?

• AI, automation and autonomous supply-chain operations
• Preparing today's workforce and infrastructure for tomorrow